- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/30 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 277/30
Total number of patents in this class: 334
10-year publication summary
|
41
|
18
|
27
|
19
|
22
|
14
|
20
|
16
|
12
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genzyme Corporation | 1308 |
12 |
| EyePoint Pharmaceuticals, Inc. | 99 |
10 |
| Cyteir Therapeutics, Inc. | 42 |
10 |
| Corteva Agriscience LLC | 2709 |
10 |
| F. Hoffmann-La Roche AG | 7931 |
7 |
| Gilead Sciences, Inc. | 2083 |
7 |
| Taisho Pharmaceutical Co., Ltd. | 858 |
7 |
| Receptos LLC | 62 |
6 |
| Vectus Biosystems Limited | 35 |
6 |
| Bristol-myers Squibb Company | 4833 |
5 |
| President and Fellows of Harvard College | 6028 |
5 |
| Takeda Pharmaceutical Company Limited | 2719 |
5 |
| BioMarin Pharmaceutical Inc. | 377 |
5 |
| Blade Therapeutics, Inc. | 19 |
5 |
| Kissei Pharmaceutical Co., Ltd. | 179 |
5 |
| Xwpharma Ltd. | 60 |
5 |
| Arcus Biosciences, Inc. | 142 |
4 |
| Canopy Growth Corporation | 223 |
4 |
| Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 53 |
4 |
| Toyama Chemical Co., Ltd. | 99 |
4 |
| Other owners | 208 |